Turning Point Therapeutics, Inc. - Common stock (TPTX) News

Turning Point Therapeutics, Inc. - Common stock (TPTX): $76.01

0.52 (+0.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TPTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of NR

in industry

Filter TPTX News Items

TPTX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest TPTX News From Around the Web

Below are the latest news stories about Turning Point Therapeutics Inc that investors may wish to consider to help them evaluate TPTX as an investment opportunity.

Turning Point Therapeutics (TPTX) Investor Presentation - Slideshow

The following slide deck was published by Turning Point Therapeutics, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 21, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5617 seconds.